Study 28020
Healthy Ages 18-55 - Earn up to $8,000. Payment will be paid throughout the study.
If you've previously submitted an application, call 417-831-2048 to enroll. Or submit your application now.
Participant Requirements: Men and Women, ages 18-55, non-tobacco users for 3 months. . Females must agree to use a highly effective contraception with lower dependency during the study and for at least 3 months before the first dose and agree to use the same method for at least 1 month after dose, such as IUD (with or without hormone), depo or implant or be surgically sterile via bilateral insertion of Essure (6 months prior), bilateral tubal ligation, hysterectomy and/or bilateral oophorectomy or be postmenopausal for at least 1 year. BMI (Body Mass Index) must be between 18-30.
What: This clinical research trial will be testing the effects of an investigational medication used to treat Cushing's Syndrome under fasting conditions.
When: This study will consist of 4, 6 day stays.. Study dates are as follows:
Group 1
Visit DatesHow Much: $8,000
Physical: Wednesday, January 13, 2021
All study dates are tentative and subject to change.
We will update the study list every Wednesday. Be sure to check with us either by calling or by looking online. Call (417) 831-2048 or come by 1820 West Mt. Vernon for more information. Office hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
At QPS, the health and safety of our participants, employees, families and communities is of the utmost importance during this time and will be enrolling studies as soon as possible!
Due to the COVID-19 Pandemic, you are now able to sign up for this particular study by clicking the "Sign-Up Button" below and a QPS Recruiting Coordinator will contact you directly.
If you haven’t already, please fill out an application and a QPS Recruiting Coordinator will contact you
Referral Program
Don't forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.*
*No referral bonuses are paid out for outpatient vaccine studies.
